AR049995A1 - Un procedimiento de preparacion de derivados n-piperidino-1,5-difenilpirazol-3-carboxamida - Google Patents
Un procedimiento de preparacion de derivados n-piperidino-1,5-difenilpirazol-3-carboxamidaInfo
- Publication number
- AR049995A1 AR049995A1 ARP050102971A ARP050102971A AR049995A1 AR 049995 A1 AR049995 A1 AR 049995A1 AR P050102971 A ARP050102971 A AR P050102971A AR P050102971 A ARP050102971 A AR P050102971A AR 049995 A1 AR049995 A1 AR 049995A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- group
- halogen atom
- alkyl
- difenilpirazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Addiction (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Reivindicacion 1: Procedimiento de preparacion de un compuesto de formula (1), donde: R1 representa un átomo de hidrogeno o de halogeno o un grupo C1-4 alquilo; R2, R3, R4, R5, R6, R7 representan cada uno, independientemente uno del otro, un átomo de hidrogeno o de halogeno o un grupo C1-4 alquilo, C1-4 alcoxi, trifluorometilo; y de sus sales, caracterizado porque: se hace reaccionar un derivado de pentano de formula: X-(CH2)5-X', donde X y X' representan, cada una independientemente, un átomo de halogeno o un grupo YSO2O- donde Y representa un grupo C1-4 alquilo, C1-4 perfluoroalquilo, fenilo no sustituido o sustituido por un grupo metilo, cloro o nitro, sobre un derivado de pirazol-3-carbohidrazida de formula (2), donde R1, R2, R3, R4, R5 R6, R7 son tales como se definieran anteriormente para la formula (1) en presencia de una base, en un solvente y a una temperatura comprendida entre la temperatura ambiente y la temperatura de reflujo del solvente.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0408111A FR2873372B1 (fr) | 2004-07-22 | 2004-07-22 | Procede de preparation de derives n-piperidino-1,5- diphenylpyrazole-3-carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR049995A1 true AR049995A1 (es) | 2006-09-20 |
Family
ID=34949586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050102971A AR049995A1 (es) | 2004-07-22 | 2005-07-19 | Un procedimiento de preparacion de derivados n-piperidino-1,5-difenilpirazol-3-carboxamida |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7462632B2 (es) |
| EP (1) | EP1773783B1 (es) |
| JP (1) | JP4879175B2 (es) |
| KR (1) | KR20070036050A (es) |
| CN (1) | CN100537543C (es) |
| AR (1) | AR049995A1 (es) |
| AT (1) | ATE466843T1 (es) |
| AU (1) | AU2005276350A1 (es) |
| BR (1) | BRPI0510399A (es) |
| CA (1) | CA2564223A1 (es) |
| DE (1) | DE602005021110D1 (es) |
| FR (1) | FR2873372B1 (es) |
| IL (1) | IL179107A0 (es) |
| MA (1) | MA28576B1 (es) |
| MX (1) | MXPA06012954A (es) |
| NO (1) | NO20071008L (es) |
| RU (1) | RU2329252C1 (es) |
| TW (1) | TW200609223A (es) |
| UY (1) | UY29023A1 (es) |
| WO (1) | WO2006021652A1 (es) |
| ZA (1) | ZA200609639B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1816125A1 (en) * | 2006-02-02 | 2007-08-08 | Ranbaxy Laboratories, Ltd. | Novel crystalline forms of an antagonist of CB1 cannabinoid receptor and preparation method thereof |
| US20100076022A1 (en) * | 2006-09-01 | 2010-03-25 | Hetero Drugs Limited | Novel polymorphs of rimonabant |
| EP2061783A2 (en) * | 2006-09-11 | 2009-05-27 | Hetero Drugs Limited | Improved process for rimonabant |
| WO2008035023A1 (en) * | 2006-09-19 | 2008-03-27 | Cipla Limited | Polymorphs of rimonabant |
| EP1944297A1 (en) * | 2007-01-09 | 2008-07-16 | Miklós Vértessy | Solid and crystalline rimonabant and processes for preparation, and pharmaceutical composition thereof |
| EP1947090A1 (en) * | 2007-01-17 | 2008-07-23 | Laboratorios del Dr. Esteve S.A. | Method for preparing N-piperidino-1,5-diphenylpyrazole-3-carboxamide and derivatives |
| WO2008088900A2 (en) * | 2007-01-18 | 2008-07-24 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of rimonabant base and processes for preparation thereof |
| WO2008102367A1 (en) * | 2007-02-19 | 2008-08-28 | Darmesh Mahendrabhai Shah | Process for preparation of pyrazole derivatives |
| FR2913018A1 (fr) * | 2007-02-23 | 2008-08-29 | Sanofi Aventis Sa | Solution solide amorphe contenant un derive de pyrazole-3-carboxamide sous forme amorphe et des excipients stabilisateurs |
| WO2009109222A1 (en) * | 2008-03-04 | 2009-09-11 | Maprimed, S. A. | Process for the preparation of rimonabant |
| WO2010079241A1 (es) | 2009-01-12 | 2010-07-15 | Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion | Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2713225B1 (fr) * | 1993-12-02 | 1996-03-01 | Sanofi Sa | N-pipéridino-3-pyrazolecarboxamide substitué. |
| FR2714057B1 (fr) * | 1993-12-17 | 1996-03-08 | Sanofi Elf | Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant. |
| JP4314339B2 (ja) * | 2002-08-22 | 2009-08-12 | 三井化学アグロ株式会社 | ニコチンアミドラゾン誘導体 |
-
2004
- 2004-07-22 FR FR0408111A patent/FR2873372B1/fr not_active Expired - Fee Related
-
2005
- 2005-07-19 AR ARP050102971A patent/AR049995A1/es unknown
- 2005-07-19 UY UY29023A patent/UY29023A1/es not_active Application Discontinuation
- 2005-07-20 BR BRPI0510399-1A patent/BRPI0510399A/pt not_active IP Right Cessation
- 2005-07-20 KR KR1020067024365A patent/KR20070036050A/ko not_active Application Discontinuation
- 2005-07-20 AU AU2005276350A patent/AU2005276350A1/en not_active Abandoned
- 2005-07-20 CA CA002564223A patent/CA2564223A1/fr not_active Abandoned
- 2005-07-20 DE DE602005021110T patent/DE602005021110D1/de active Active
- 2005-07-20 EP EP05790868A patent/EP1773783B1/fr active Active
- 2005-07-20 ZA ZA200609639A patent/ZA200609639B/xx unknown
- 2005-07-20 CN CNB2005800163474A patent/CN100537543C/zh not_active Expired - Fee Related
- 2005-07-20 RU RU2006141239/04A patent/RU2329252C1/ru not_active IP Right Cessation
- 2005-07-20 JP JP2007521985A patent/JP4879175B2/ja not_active Expired - Fee Related
- 2005-07-20 WO PCT/FR2005/001850 patent/WO2006021652A1/fr active Application Filing
- 2005-07-20 AT AT05790868T patent/ATE466843T1/de not_active IP Right Cessation
- 2005-07-20 MX MXPA06012954A patent/MXPA06012954A/es not_active Application Discontinuation
- 2005-07-21 TW TW094124731A patent/TW200609223A/zh unknown
-
2006
- 2006-11-07 IL IL179107A patent/IL179107A0/en unknown
- 2006-11-10 MA MA29444A patent/MA28576B1/fr unknown
- 2006-11-14 US US11/559,566 patent/US7462632B2/en not_active Expired - Fee Related
-
2007
- 2007-02-21 NO NO20071008A patent/NO20071008L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006021652A1 (fr) | 2006-03-02 |
| MXPA06012954A (es) | 2007-02-12 |
| BRPI0510399A (pt) | 2007-11-13 |
| ZA200609639B (en) | 2008-08-27 |
| UY29023A1 (es) | 2006-02-24 |
| AU2005276350A1 (en) | 2006-03-02 |
| JP4879175B2 (ja) | 2012-02-22 |
| FR2873372A1 (fr) | 2006-01-27 |
| JP2008506756A (ja) | 2008-03-06 |
| CN1956963A (zh) | 2007-05-02 |
| EP1773783B1 (fr) | 2010-05-05 |
| CN100537543C (zh) | 2009-09-09 |
| DE602005021110D1 (de) | 2010-06-17 |
| NO20071008L (no) | 2007-02-21 |
| US20080119653A1 (en) | 2008-05-22 |
| MA28576B1 (fr) | 2007-05-02 |
| KR20070036050A (ko) | 2007-04-02 |
| ATE466843T1 (de) | 2010-05-15 |
| US7462632B2 (en) | 2008-12-09 |
| RU2329252C1 (ru) | 2008-07-20 |
| TW200609223A (en) | 2006-03-16 |
| FR2873372B1 (fr) | 2006-09-08 |
| EP1773783A1 (fr) | 2007-04-18 |
| CA2564223A1 (fr) | 2006-03-02 |
| IL179107A0 (en) | 2007-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR049995A1 (es) | Un procedimiento de preparacion de derivados n-piperidino-1,5-difenilpirazol-3-carboxamida | |
| EA201170096A1 (ru) | Замещенные производные пиримидона | |
| AR054799A1 (es) | Derivados de oxindol | |
| AR051485A1 (es) | Pirazolo pirimidinas 1,4-sustituidas como inhibidores de quinasa | |
| CO5690643A2 (es) | Derivados de triaza-espiropiperidina para usarlos como inhibidores de glyt-1 en el tratamiento de desordenes neurologicos y neuropsiquiatricos | |
| PE20050132A1 (es) | Piperazinas heterociclicas sustituidas | |
| AR049543A1 (es) | Derivados de la 1-amino-ftalazina, su preparacion y su aplicacion en terapeutica | |
| AR038536A1 (es) | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados | |
| AR052156A1 (es) | Fenil-metanonas bi- y triciclicas sustituidas para el tratamiento de trastornos neurologicos y neuropsiquiatricos | |
| ME01421B (me) | 5-supstituisani derivati kinazolinona kao protivtumorska sredstva | |
| AR049784A1 (es) | Derivados sustituidos de morfolina y tiomorfolina | |
| PE20021084A1 (es) | Ciclobuten-1,2-dionas 3,4-di-substituidas como ligandos del receptor de cxc-quimiocina | |
| CO5670367A2 (es) | Derivados de acido fenoxiacetico | |
| AR047456A1 (es) | Derivados de amidas, procesos para su preparacion y uso como insecticidas | |
| AR052866A1 (es) | Fenil-metanonas monociclicas sustituidas | |
| AR060604A1 (es) | Nuevos arilamino n- heteroarilos como inhibidores de mek | |
| AR054102A1 (es) | Derivados de fenil-piperazina-metanona. procesos de obtencion y composiciones farmaceuticas | |
| AR057980A1 (es) | Derivados de la 1- amino-ftalazina sustituida, su preparacion y composicion farmaceutica | |
| AR042362A1 (es) | Derivados de 3h-quinazolin-4-ona, proceso de obtencion y composiciones farmaceuticas que los contienen | |
| AR036602A1 (es) | Agonistas muscarinicos | |
| RU2006137563A (ru) | Способ получения аминофенольных соединений | |
| AR066603A1 (es) | Derivados de arilamida pirimidona | |
| AR055666A1 (es) | Inhibidores inntr | |
| AR056874A1 (es) | Derivados de 6- heteroarilpiridoindolona, su preparacion y su aplicacion en terapeutica | |
| PE20021003A1 (es) | Fenil-heterociclil-eteres como inhibidores selectivos de la recaptacion de serotonina (ssri) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |